Vaccines and treatments are in trials, but the virus remains a leading killer of infants worldwide.
Tag: GlaxoSmithKline PLC
The F.D.A. Suspends Use of Glaxo Antibody Drug in the U.S.
Manufacturers said lab testing revealed that the authorized dosage of the drug was not sufficiently potent against BA.2.
A Glaxo antibody drug is restricted in the U.S. Northeast as an Omicron subvariant spreads.
The move leaves doctors in the region with one less option to treat high-risk Covid patients.
Novel Malaria Treatment for Children Receives First Approval
The single-dose medication, for treatment of a particular form of malaria, is a new weapon in the war against the deadly illness.
Africans Welcome New Malaria Vaccine. But Is It a ‘Game Changer’?
The arsenal of weapons to use against malaria, which kills hundreds of thousands of people annually, just grew bigger.
First Malaria Vaccine Approved by W.H.O.
Malaria kills about 500,000 people each year, about half of them children in Africa. The new vaccine isn’t perfect, but it will help turn the tide, experts said.
Moncef Slaoui, the former head of Operation Warp Speed, was fired from a biotech company after sexual misconduct allegations.
GlaxoSmithKline, the pharmaceutical company, said on Wednesday that it had fired Dr. Slaoui from his position as chairman of Galvani Bioelectronics.
Moderna Vaccine Is Highly Protective and Prevents Severe Covid, Data Show
The positive review most likely ensures that the Food and Drug Administration will grant emergency authorization to a second coronavirus vaccine this week for millions of Americans.
Sanofi Accelerates Its Timeline for Coronavirus Vaccine Development
The French drugmaker is testing two types of vaccines in a bid to catch up to competitors.
U.K. Paid $20 Million for New Coronavirus Tests. They Didn’t Work.
Facing a global scramble for materials, British officials bought millions of unproven kits from China in a gamble that became an embarrassment.